So similar, yet so different: Selective translation of capped and polyadenylated viral mRNAs in the influenza virus infected cell

Virus Research

Volumn 156, Issue 1-2, 2011, Pages 1-12

  Yángüez, Emilio ^a,b   Nieto, Amelia ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

EIF4E; Influenza virus; NS1; Translation

Indexed keywords

CAPPED RNA; CELL PROTEIN; HUMAN STAUFEN1 PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4F; INITIATION FACTOR 4G; INTERFERON; LA ANTIGEN; NONSTRUCTURAL PROTEIN 1; POLYADENYLATED RNA; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN KINASE R; PROTEIN SUBUNIT; RAPAMYCIN; RNA POLYMERASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS MESSENGER RNA; VIRUS POLYMERASE; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ADENOVIRUS INFECTION; CYTOKINE RELEASE; DRUG MECHANISM; GENE EXPRESSION; HOST CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INFLUENZA; INFLUENZA VIRUS; INHIBITION KINETICS; MIXED INFECTION; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REDUCTION KINETICS; REVIEW; RNA DEGRADATION; RNA TRANSLATION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS MUTANT; VIRUS PARTICLE; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

ANIMALS; EUKARYOTIC INITIATION FACTOR-4F; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; ORTHOMYXOVIRIDAE; RNA REPLICASE; RNA, MESSENGER; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

ORTHOMYXOVIRIDAE;

EID: 79951809442     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.12.016     Document Type: Review

References (134)

1. Ali N., Siddiqui A. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(6):2249-2254.
2. Aragón T., de la Luna S., Novoa I., Carrasco L., Ortín J., Nieto A. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 2000, 20(17):6259-6268.
3. Barber G.N., Thompson S., Lee T.G., Strom T., Jagus R., Darveau A., Katze M.G. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(10):4278-4282.
4. Basler C.F., García-Sastre A. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 2002, 21(4-5):305-337.
5. Beloso A., Martínez C., Valcárcel J., Fernández-Santarén J., Ortín J. Degradation of cellular mRNA during influenza virus infection: its possible role in protein synthesis shutoff. J. Gen. Virol. 1992, 73:575-581.
6. Belsham G.J., Jackson R.J. Translation initiation on picornavirus RNA. Translational Control of Gene Expression 2000, 869-900. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.).
7. Belsham G.J., Sonenberg N. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 1996, 60(3):499-511.
8. Belsham G.J., Sonenberg N. Picornavirus RNA translation: roles for cellular proteins. Trends Microbiol. 2000, 8(7):330-335.
9. Beretta L., Gingras A.C., Svitkin Y.V., Hall M.N., Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 1996, 15(3):658-664.
10. Bergmann M., García-Sastre A., Carnero E., Pehamberger H., Wolff K., Palese P., Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 2000, 74:6203-6206.
11. Blaas D., Patzelt E., Keuchler E. Identification of the cap binding protein of influenza virus. Nucleic Acids Res. 1982, 10:4803-4812.
12. Borman A.M., Michel Y.M., Kean K.M. Biochemical characterisation of cap-poly(A) synergy in rabbit reticulocyte lysates: the eIF4G-PABP interaction increases the functional affinity of eIF4E for the capped mRNA 5′-end. Nucleic Acids Res. 2000, 28(21):4068-4075.
13. Bouloy M., Plotch S.J., Krug R.M. Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:4886-4890.
14. Burd C.G., Matunis E.L., Dreyfus G. The multiple RNA-binding domains of the mRNA poly(A)-binding protein have different RNA-binding activities. Mol. Cell. Biol. 1991, 11:3419-3424.
15. Burgui I., Aragón T., Ortín J., Nieto A. PABP1 and eIF4GI associate to influenza virus NS1 protein in viral mRNA translation initiation complexes. J. Gen. Virol. 2003, 84:3263-3274.
16. Burgui I., Yángüez E., Sonenber N., Nieto A. Influenza mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?. J. Virol. 2007, 81(22):12427-12438.
17. Bushell M., Sarnow P. Hijacking the translation apparatus by RNA viruses. J. Cell Biol. 2002, 158(3):395-399.
18. Cardinali B., Carissimi C., Gravina P., Pierandrei-Amaldi P. La protein is associated with terminal oligopyrimidine mRNAs in actively translating polysomes. J. Biol. Chem. 2003, 278(37):35145-35151.
19. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 1997, 17(9):503-524.
20. Crosio C., Boyl P.P., Loreni F., Pierandrei-Amaldi P., Amaldi F. La protein has a positive effect on the translation of TOP mRNAs in vivo. Nucleic Acids Res. 2000, 28(15):2927-2934.
21. Cuesta R., Xi Q., Schneider R.J. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J. 2000, 19(13):3465-3474.
22. Chen Z., Li Y., Krug R.M. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 1999, 18(8):2273-2283.
23. Cheng A., Wong S.M., Yuan Y.A. Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res. 2009, 19(2):187-195.
24. de la Luna S., Fortes P., Beloso A., Ortín J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 1995, 69(4):2427-2433.
25. de Lucas S., Peredo J., Marión R.M., Sanchez C., Ortín J. Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication. J. Virol. 2010, 84(15):7603-7612.
26. Dias A., Bouvier D., Crepin T., McCarthy A.A., Hart D.J., Baudin F., Cusack S., Ruigrok R.W. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458(7240):914-918.
27. Egorov A., Brandt S., Sereining S., Romanova J., Ferko B., Katinger D., Grassauer A., Alexandrova G., Katinger H., Muster T. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J. Virol. 1998, 72:6437-6441.
28. Enami K., Sato T.A., Nakada S., Enami M. Influenza virus NS1 protein stimulates translation of the M1 protein. J. Virol. 1994, 68(3):1432-1437.
29. Falcón A., Fortes P., Marión R.M., Beloso A., Ortín J. Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res. 1999, 27(11):2241-2247.
30. Falcón A., Marión R., Zürcher T., Gomez P., Portela A., Nieto A., Ortín J. Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J. Virol. 2004, 78:3880-3888.
31. Feigenblum D., Schneider R.J. Modification of eukaryotic initiation factor 4F during infection by influenza virus. J. Virol. 1993, 67(6):3027-3035.
32. Fortes P., Beloso A., Ortín J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks RNA nucleocytoplasmic transport. EMBO J. 1994, 13:704-712.
33. Fortes P., Lamond A.I., Ortín J. Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J. Gen. Virol. 1995, 76:1001-1007.
34. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., Farzan M., Inoue S., Jung J.U., García-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5(5):439-449.
35. Gallie D.R. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev. 1991, 5(11):2108-2116.
36. García-Sastre A., Egorov A., Matassov D., Brandt S., Levy D.E., Durbin J.E., Palese P., Muster T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998, 252:324-330.
37. Garfinkel M.S., Katze M.G. Translational control by influenza virus. Selective and cap-dependent translation of viral mRNAs in infected cells. J. Biol. Chem. 1992, 267(13):9383-9390.
38. Garfinkel M.S., Katze M.G. Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5′-untranslated region. J. Biol. Chem. 1993, 268(30):22223-22226.
39. Gingras A.C., Gygi S.P., Raught B., Polakiewicz R.D., Abraham R.T., Hoekstra M.F., Aebersold R., Sonenberg N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999, 13(11):1422-1437.
40. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 1999, 68:913-963.
41. Gonzalez S., Ortín J. Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J. 1999, 18(13):3767-3775.
42. Gradi A., Imataka H., Svitkin Y.V., Rom E., Raught B., Morino S., Sonenberg N. A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 1998, 18(1):334-342.
43. Graef K.M., Vreede F.T., Lau Y.F., McCall A.W., Carr S.M., Subbarao K., Fodor E. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J. Virol. 2010, 84(17):8433-8445.
44. Gray N.K., Wickens M. Control of translation initiation in animals. Annu. Rev. Cell. Dev. Biol. 1998, 14:399-458.
45. Guilligay D., Tarendeau F., Resa-Infante P., Coloma R., Crepin T., Sehr P., Lewis J., Ruigrok R.W., Ortín J., Hart D.J., Cusack S. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 2008, 15(5):500-506.
46. Guo Z., Chen L.M., Zeng H., Gomez J.A., Plowden J., Fujita T., Katz J.M., Donis R.O., Sambhara S. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 2007, 36(3):263-269.
47. Hale B.G., Randall R.E., Ortín J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89(Pt 10):2359-2376.
48. Hooker L., Sully R., Handa B., Ono N., Koyano H., Klumpp K. Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E. Biochemistry 2003, 42(20):6234-6240.
49. Hoshino S., Imai M., Kobayashi T., Uchida N., Katada T. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3′-poly(A) tail of mRNA. J. Biol. Chem. 1999, 274(24):16677-16680.
50. Imataka H., Gradi A., Sonenberg N. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 1998, 17:7480-7489.
51. Inglis S.C. Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and Herpes simplex virus. Mol. Cell. Biol. 1982, 2:1644-1648.
52. Iwai A., Shiozaki T., Kawai T., Akira S., Kawaoka Y., Takada A., Kida H., Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon {beta} promoter stimulator 1. J. Biol. Chem. 2010, 285(42):32064-32074.
53. Kahvejian A., Svitkin Y.V., Sukarieh R., M'Boutchou M.N., Sonenberg N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev. 2005, 19(1):104-113.
54. Kash J.C., Cunningham D.M., Smit M.W., Park Y., Fritz D., Wilusz J., Katze M.G. Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis. J. Virol. 2002, 76(20):10417-10426.
55. Katze M.G., Chen Y.T., Krug R.M. Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell 1984, 37(2):483-490.
56. Katze M.G., DeCorato D., Krug R.M. Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus. J. Virol. 1986, 60(3):1027-1039.
57. Katze M.G., Detjen B.M., Safer B., Krug R.M. Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol. Cell. Biol. 1986, 6(5):1741-1750.
58. Katze M.G., Krug R.M. Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol. Cell. Biol. 1984, 4(10):2198-2206.
59. Katze M.G., Krug R.M. Translational control in influenza virus-infected cells. Enzyme 1990, 44(1-4):265-277.
60. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6(10):981-988.
61. Kim Y.K., Jang S.K. La protein is required for efficient translation driven by encephalomyocarditis virus internal ribosomal entry site. J. Gen. Virol. 1999, 80(Pt 12):3159-3166.
62. Kochs G., García-Sastre A., Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 2007, 81(13):7011-7021.
63. Korneeva N.L., Lamphear B.J., Hennigan F.L., Merrick W.C., Rhoads R.E. Characterization of the two eIF4A-binding sites on human eIF4G-1. J. Biol. Chem. 2001, 276(4):2872-2879.
64. Korneeva N.L., Lamphear B.J., Hennigan F.L., Rhoads R.E. Mutually cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eIF4G-1. J. Biol. Chem. 2000, 275(52):41369-41376.
65. Krug R.M., Broni B.A., Bouloy M. Are the 5′-ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs?. Cell 1979, 18:329-334.
66. Krug R.M., Etkind P.R. Cytoplasmic and nuclear specific proteins in influenza virus-infected MDCK cells. Virology 1973, 56:334-348.
67. Kühn U., Pieler T. Xenopus poly(A) binding protein: functional domains in RNA binding and protein-protein interaction. J. Mol. Biol. 1996, 256:20-30.
68. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 2006, 203(7):1795-1803.
69. Lamb R.A., Choppin P.W., Chanock R.M., Lai C.J. Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc. Natl. Acad. Sci. U.S.A. 1980, 77(4):1857-1861.
70. Lamb R.A., Krug R.M. Orthomyxoviridae: the viruses and their replication. Fields Virology 2001, 1487-1579. Lippincott Williams & Wilkins, Philadelphia, U.S.A. 4th ed. P.M. Howley (Ed.).
71. Lamphear B.J., Kirchweger R., Skern T., Rhoads R.E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornavirus proteases-implication for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 1995, 270:21975-21983.
72. Le H., Tanguay R.L., Balasta M.L., Wei C.C., Browning K.S., Metz A.M., Goss D.J., Gallie D.R. Translation initiation factors eIF-iso4G and eIF-4B interact with the poly(A)-binding protein and increase its RNA binding activity. J. Biol. Chem. 1997, 272(26):16247-16255.
73. Lee T.G., Tang N., Thompson S., Miller J., Katze M.G. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 1994, 14(4):2331-2342.
74. Levy D.E., García-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 2001, 12(2-3):143-156.
75. Li S., Min J.Y., Krug R.M., Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006, 349(1):13-21.
76. Ling J., Morley S.J., Traugh J.A. Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2. EMBO J. 2005, 24(23):4094-4105.
77. Lu Y., Wambach M., Katze M.G., Krug R.M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 1995, 214(1):222-228.
78. Luo G.X., Luytjes W., Enami M., Palese P. The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J. Virol. 1991, 65(6):2861-2867.
79. Mader S., Lee H., Pause A., Sonenberg N. The translation initiation factor eIF-4E binds to a common motif share by the translation faftor eIF-gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 1995, 15:4990-4997.
80. Marión R.M., Fortes P., Beloso A., Dotti C., Ortín J. A human sequence homologue of Staufen is an RNA binding protein that is associated to polysomes and localizes to the rough endoplasmic reticulum. Mol. Cell. Biol. 1999, 19(3):2212-2219.
81. Marión R.M., Zürcher T., de la Luna S., Ortín J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J. Gen. Virol. 1997, 78:2447-2451.
82. Martinez-Salas E. Impact of RNA structure in picornavirus IRES activity. Trends Microbiol. 2008, 16:230-237.
83. Martinez-Salas E., Fernandez-Miragall O. Picornavirus IRES: structure function relationship. Curr. Pharm. Des. 2004, 10(30):3757-3767.
84. Melville M.W., Tan S.L., Wambach M., Song J., Morimoto R.I., Katze M.G. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity. J. Biol. Chem. 1999, 274(6):3797-3803.
85. Merrick W.C., Hershey J.W.B. The pathway and mechanism of protein synthesis. Translational Control 1996, 31-70. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.).
86. Mibayashi M., Martinez-Sobrido L., Loo Y.M., Cardenas W.B., Gale M., García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 2007, 81(2):514-524.
87. Min J.Y., Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(18):7100-7105.
88. Nemeroff M.E., Barabino S.M.L., Li Y., Keller W., Krug R.M. Influenza virus NS1 protein interacts with the cellular 30kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol. Cell. 1998, 1:991-1000.
89. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459(7249):931-939.
90. Neuman-Silberberg F.S., Schupbach T. Dorsoventral axis formation in Drosophila depends on the correct dosage of the gene gurken. Development 1994, 120(9):2457-2463.
91. Opitz B., Rejaibi A., Dauber B., Eckhard J., Vinzing M., Schmeck B., Hippenstiel S., Suttorp N., Wolff T. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol. 2007, 9(4):930-938.
92. Park Y.W., Katze M.G. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J. Biol. Chem. 1995, 270(47):28433-28439.
93. Park Y.W., Wilusz J., Katze M.G. Regulation of eukaryotic protein synthesis: selective influenza viral mRNA translation is mediated by the cellular RNA-binding protein GRSF-1. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6694-6699.
94. Pe'ery T., Mathews M.B. Viral translational strategies and host defense mechanisms. Translational Control of Gene expression 2000, 371-424. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.).
95. Pestka S., Langer J.A., Zoon K.C., Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 1987, 56:727-777.
96. Pestova T.V., Kolupaeva V.G., Lomakin I.B., Pilipenko E.V., Shatsky I.N., Agol V.I., Hellen C.U. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(13):7029-7036.
97. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006, 314(5801):997-1001.
98. Plotch S.J., Bouloy M., Ulmanen I., Krug R.M. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 1981, 23:847-858.
99. Polyak S.J., Tang N., Wambach M., Barber G.N., Katze M.G. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity. J. Biol. Chem. 1996, 271:1702-1707.
100. Poon L.M., Pritlove D.C., Sharp J., Brownlee G.G. The RNA polymerase of influenza virus, bound to the 5′ end of virion RNA, acts in cis to polyadenylate mRNA. J. Virol. 1998, 72(10):8214-8219.
101. Poon L.L., Pritlove D.C., Fodor E., Brownlee G.G. Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J. Virol. 1999, 73(4):3473-3476.
102. Pritlove D.C., Poon L.L., Devenish L.J., Leahy M.B., Brownlee G. A hairpin loop at the 5′ end of influenza A virus virion RNA is required for synthesis of poly(A)+mRNA in vitro. J. Virol. 1999, 73(3):109-114.
103. Proud C.G. PKR: a new name and new roles. Trends Biochem Sci 1995, 20(6):241-246.
104. Pyronnet S., Imataka H., Gingras A.-C., Fukunaga R., Hunter T., Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk 1 to phosphorylate eIF4E. EMBO J. 1999, 1:270-279.
105. Qian Z., Wilusz J. GRSF-1: a poly(A)+mRNA binding protein which interacts with a conserved G-rich element. Nucleic Acids Res. 1994, 22(12):2334-2343.
106. Qiu Y., Nemeroff M., Krug R.M. The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1995, 1(3):304-316.
107. Rehwinkel J. Exposing viruses: RNA patterns sensed by RIG-I-like receptors. J. Clin. Immunol. 2010, 30(4):491-495.
108. Rehwinkel J., Reis e Sousa C. RIGorous detection: exposing virus through RNA sensing. Science 2010, 327(5963):284-286.
109. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., Reis e Sousa C. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140(3):397-408.
110. Richter J.D., Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005, 433(7025):477-480.
111. Robertson J.S., Schubert M., Lazzarini R.A. Polyadenylation sites for influenza mRNA. J. Virol. 1981, 38:157-163.
112. Rodriguez A., Perez-Gonzalez A., Hossain M.J., Chen L.M., Rolling T., Perez-Brena P., Donis R., Kochs G., Nieto A. Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. J. Virol. 2009, 83(21):11166-11174.
113. Rodriguez A., Pérez-Gonzalez A., Nieto A. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J. Virol. 2007, 81(10):5315-5324.
114. Ross G., Dyer J.R., Castellucci V.F., Sossin W.S. Mnk is a negative regulator of cap-dependent translation in Aplysia neurons. J. Neurochem. 2006, 97(1):79-91.
115. Salvatore M., Basler C.F., Parisien J.-P., Horvath C.M., Bourmakina S., Zheng H., Muster T., Palese P., García-Sastre A. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 2002, 76(3):1206-1212.
116. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14(4):778-809. (table of contents).
117. Scheper G.C., Proud C.G. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?. Eur. J. Biochem. 2002, 269(22):5350-5359.
118. Shih S.R., Krug R.M. Surprising function of the three influenza viral polymerase proteins: selective protection of viral mRNAs against the cap-snatching reaction catalyzed by the same polymerase proteins. Virology 1996, 226(2):430-435.
119. Shih S.R., Nemeroff M.E., Krug R.M. The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(14):6324-6328.
120. Sonenberg N., Dever T.E. Eukaryotic translation initiation factors and regulators. Curr. Opin. Struct. Biol. 2003, 13(1):56-63.
121. Sudhakar A., Ramachandran A., Ghosh S., Hasnain S.E., Kaufman R.J., Ramaiah K.V. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000, 39(42):12929-12938.
122. Tarun S.Z., Sachs A.B. Association of the yeast poly(A) tail binding protein with translation initiation factor eIF4G. EMBO J. 1996, 15:7168-7177.
123. Tarun S.Z.J., Sachs A.B. A common function for mRNA 5′ and 3′ ends in translation initiation in yeast. Genes Dev. 1995, 9:2997-3007.
124. Ulmanen I., Broni B.A., Krug R.M. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:7355-7359.
125. Villacé P., Marión R.M., Ortín J. The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 2004, 32(8):2411-2420.
126. Ward A.C., Azad A.A., Macreadie I.G. Expression and characterisation of the influenza A virus non-structural protein NS1 in yeast. Arch. Virol. 1994, 138(3-4):299-314.
127. Wei C.C., Balasta M.L., Ren J., Goss D.J. Wheat germ poly(A) binding protein enhances the binding affinity of eukaryotic initiation factor 4F and (iso)4F for cap analogues. Biochemistry 1998, 37(7):1910-1916.
128. Wells S.E., Hillner P.E., Vale R.D., Sachs A.B. Circularization of mRNA by eukaryotic translation initiation factors. Mol. Cell. 1998, 2(1):135-140.
129. Wright P.F., Webster R.G. Orthomyxoviruses. Fields Virology 2001, 1533-1579. Lippincott, Williams and Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
130. Xi Q., Cuesta R., Schneider R.J. Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev. 2004, 18(16):1997-2009.
131. Yan W., Frank C.L., Korth M.J., Sopher B.L., Novoa I., Ron D., Katze M.G. Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(25):15920-15925.
132. Yuan P., Bartlam M., Lou Z., Chen S., Zhou J., He X., Lv Z., Ge R., Li X., Deng T., Fodor E., Rao Z., Liu Y. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 2009, 458(7240):909-913.
133. Zuberek J., Jemielity J., Jablonowska A., Stepinski J., Dadlez M., Stolarski R., Darzynkiewicz E. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5′ terminus. Biochemistry 2004, 43(18):5370-5379.
134. Zürcher T., Marión R.M., Ortín J. Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J. Virol. 2000, 74(18):8781-8784.